Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype

Eitemau Tebyg

• The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
  gan: Ragnum, H B, et al.
  Cyhoeddwyd: (2015)
• Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype
  gan: Barathova, M, et al.
  Cyhoeddwyd: (2008)
• Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours
  gan: Childs, Alexa, et al.
  Cyhoeddwyd: (2016)
• Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression
  gan: Couvelard, A, et al.
  Cyhoeddwyd: (2005)
• PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness
  gan: Molleví, D G, et al.
  Cyhoeddwyd: (2008)